On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...
On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development...
“Our studies are open for those that have exhausted standard of care, and we're showing improved responses, and the data is promising. So, I...